Opinion: Paxlovid is not fully accessible to those who need it most: the immunocompromised
The pandemic is over for most of the world. But for the 2.7% of adults in the United States who are immunocompromised, it isn’t.
I’m one of them. As we are all increasingly expected to return to pre-pandemic routines, including traveling abroad, those of us with a weakened immune system are attempting to be proactive — to plan ahead for possible illness. Our health care system is making that difficult.
